FGF23 and rickets: Anti‐FGF23 neutralizing antibody therapy such as burosumab has emerged as a safe and effective treatment for X‐linked hypophosphatemia and can rapidly stabilize serum phosphate levels and lead to improvements in rickets, skeletal healing, and physical function.